U.S. flag

An official website of the United States government

NM_000488.4(SERPINC1):c.408+4C>T AND Hereditary antithrombin deficiency

Germline classification:
Likely benign (3 submissions)
Last evaluated:
Jul 25, 2023
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001101590.6

Allele description [Variation Report for NM_000488.4(SERPINC1):c.408+4C>T]

NM_000488.4(SERPINC1):c.408+4C>T

Gene:
SERPINC1:serpin family C member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q25.1
Genomic location:
Preferred name:
NM_000488.4(SERPINC1):c.408+4C>T
HGVS:
  • NC_000001.11:g.173914549G>A
  • NG_012462.1:g.7830C>T
  • NM_000488.4:c.408+4C>TMANE SELECT
  • NM_001365052.2:c.264+4C>T
  • NM_001386302.1:c.408+4C>T
  • NM_001386303.1:c.489+4C>T
  • NM_001386304.1:c.408+4C>T
  • NM_001386305.1:c.408+4C>T
  • NM_001386306.1:c.408+4C>T
  • LRG_577t1:c.408+4C>T
  • LRG_577:g.7830C>T
  • NC_000001.10:g.173883687G>A
  • NM_000488.3:c.408+4C>T
Links:
dbSNP: rs201551398
NCBI 1000 Genomes Browser:
rs201551398
Molecular consequence:
  • NM_000488.4:c.408+4C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001365052.2:c.264+4C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001386302.1:c.408+4C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001386303.1:c.489+4C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001386304.1:c.408+4C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001386305.1:c.408+4C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001386306.1:c.408+4C>T - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Hereditary antithrombin deficiency (AT3D)
Synonyms:
Antithrombin III deficiency; Thrombophilia due to antithrombin III deficiency; Reduced antithrombin III activity; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0013144; MedGen: C0272375; OMIM: 613118; Human Phenotype Ontology: HP:0001976

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001258213Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 13 December 2019)
Uncertain significance
(Apr 27, 2017)
germlineclinical testing

Citation Link,

SCV002785974Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Aug 23, 2021)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004037385Clingen Thrombosis Variant Curation Expert Panel, ClinGen
reviewed by expert panel

(ClinGen ACMG Specifications SERPINC1 V1.0.0)
Likely benign
(Jul 25, 2023)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Illumina Laboratory Services, Illumina, SCV001258213.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Fulgent Genetics, Fulgent Genetics, SCV002785974.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Clingen Thrombosis Variant Curation Expert Panel, ClinGen, SCV004037385.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The NM_000488.4(SERPINC1):c.408+4C>T variant is an intronic variant reported at a POPMAX FAF of 0.0003794 in the South Asian population (18/30616 alleles) meeting BS1 criteria. SpliceAI and VarSEAK predict no splicing impact for this variant; however the nucleotide may be conserved based on PhyloP and PhastCons scores (BP4). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Thrombosis Variant Curation Expert Panel for AT Deficiency for SERPINC1: BS1, BP4.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024